# pathway_0177: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0177.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Secondary metabolite biosynthesis

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSQPEFTRSIVGASFLLPVINGAMHIPPAVSATRVTLEDNQPRDAPILVLLFALSVLIDVMDKAADLPRQTRKTWLMTIVVFASPFVVLAVYGTMHCGLLALLRLLGVPLLAVVHAMPLIPVYSWKTGSISTVKLKYFLGPFKSLFGATCIGLMDVTAVVLYLRGTMLHPENASSAGHFRVLMYTITYDFLWESICDVRDIQEDEQNNITTLATAFGVRPTLIFLGGSTMMGDLSITLLGGGSAVLSVVRSTVFWGAFAALALHKPRSAVYPWGLATLFGLLPVWLASLGART

[Multiple Choices]
A. Metabolic intermediate biosynthesis
B. Secondary metabolite biosynthesis
C. peptidoglycan degradation. .
D. L-histidine from 5-phospho-alpha-D-ribose 1-diphosphate: step 4/9. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact-matching UniProt record annotates this protein to secondary metabolite biosynthesis, specifically terpenoid biosynthesis, and identifies it as prenyltransferase vviA. The pathway annotation is attributed to a publication with experimental evidence code ECO:0000269; the primary paper was not independently reviewed here.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is strongly hydrophobic and appears to contain multiple membrane-spanning regions, but that does not identify its specific substrate, enzymatic function, or pathway among the choices.


**Missing item-specific fact**

> The protein-specific identification as prenyltransferase vviA and its role in terpenoid/secondary-metabolite biosynthesis.


**Reason**

> The supplied sequence and choices do not provide a defensible way to distinguish the specific secondary-metabolite pathway from broader metabolic biosynthesis. The answer depends on protein-specific functional annotation or equivalent external evidence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> The choices provide no sequence-based discriminator between broad metabolic intermediate biosynthesis and the more specific secondary-metabolite biosynthesis. These descriptions can also overlap; the protein-specific annotation resolves the intended choice as B.


### Important caveats

- The reviewer-only record matches the supplied sequence, including the historical record available by the stated cutoff.
- The cited database annotation attributes experimental evidence to a publication, but that primary publication was not independently assessed.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and appears to contain multiple membrane-spanning regions, but that does not identify its specific substrate, enzymatic function, or pathway among the choices.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identification as prenyltransferase vviA and its role in terpenoid/secondary-metabolite biosynthesis.",
    "reason": "The supplied sequence and choices do not provide a defensible way to distinguish the specific secondary-metabolite pathway from broader metabolic biosynthesis. The answer depends on protein-specific functional annotation or equivalent external evidence."
  },
  "case_id": "pathway_0177",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact-matching UniProt record annotates this protein to secondary metabolite biosynthesis, specifically terpenoid biosynthesis, and identifies it as prenyltransferase vviA. The pathway annotation is attributed to a publication with experimental evidence code ECO:0000269; the primary paper was not independently reviewed here."
  },
  "important_caveats": [
    "The reviewer-only record matches the supplied sequence, including the historical record available by the stated cutoff.",
    "The cited database annotation attributes experimental evidence to a publication, but that primary publication was not independently assessed."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "The choices provide no sequence-based discriminator between broad metabolic intermediate biosynthesis and the more specific secondary-metabolite biosynthesis. These descriptions can also overlap; the protein-specific annotation resolves the intended choice as B."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0177",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact-matching UniProt record annotates this protein to secondary metabolite biosynthesis, specifically terpenoid biosynthesis, and identifies it as prenyltransferase vviA. The pathway annotation is attributed to a publication with experimental evidence code ECO:0000269; the primary paper was not independently reviewed here.",
    "evidence_ids": ["C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and appears to contain multiple membrane-spanning regions, but that does not identify its specific substrate, enzymatic function, or pathway among the choices.",
    "missing_item_specific_fact": "The protein-specific identification as prenyltransferase vviA and its role in terpenoid/secondary-metabolite biosynthesis.",
    "reason": "The supplied sequence and choices do not provide a defensible way to distinguish the specific secondary-metabolite pathway from broader metabolic biosynthesis. The answer depends on protein-specific functional annotation or equivalent external evidence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "The choices provide no sequence-based discriminator between broad metabolic intermediate biosynthesis and the more specific secondary-metabolite biosynthesis. These descriptions can also overlap; the protein-specific annotation resolves the intended choice as B."
  },
  "important_caveats": [
    "The reviewer-only record matches the supplied sequence, including the historical record available by the stated cutoff.",
    "The cited database annotation attributes experimental evidence to a publication, but that primary publication was not independently assessed."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A6A6H402 (Prenyltransferase vviA / Sporulositol A biosynthesis cluster protein A) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987, a 2024 Org. Lett. paper on cyclo-farnesyl diphosphate-dependent prenylation in fungi). The sequence matches exactly (293 AA, SHA-256 confirmed). The protein catalyzes prenylation in sporulositol A biosynthesis, a fungal secondary metabolite. The expected answer B is directly supported.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> One could argue that fungal membrane-bound prenyltransferases with multiple TM domains are predominantly involved in secondary metabolite (terpenoid) biosynthesis rather than primary metabolic intermediate production. Options C (peptidoglycan degradation) and D (histidine biosynthesis) are readily excluded for a eukaryotic membrane protein. However, the critical A-vs-B distinction ('metabolic intermediate biosynthesis' vs. 'secondary metabolite biosynthesis') hinges on whether the prenylated product is a primary or secondary metabolite, which is not determinable from sequence features alone.


**Missing item-specific fact**

> The specific substrate and product identity of this enzyme (cyclo-farnesyl diphosphate-dependent prenylation producing sporulositol A, a secondary metabolite) is required to definitively assign the pathway as 'secondary metabolite biosynthesis' rather than the more generic 'metabolic intermediate biosynthesis.' Prenyltransferases can function in both primary (e.g., ubiquinone biosynthesis) and secondary metabolism, and the sequence alone does not encode which class of product is formed.


**Reason**

> While a knowledgeable model might narrow choices by recognizing prenyltransferase motifs and fungal membrane-protein architecture, the decisive distinction between option A (metabolic intermediate biosynthesis) and option B (secondary metabolite biosynthesis) depends on knowing this particular enzyme's role in sporulositol A biosynthesis—a specific experimental finding from PubMed:39310987. No general sequence heuristic reliably separates primary from secondary metabolite prenylation in fungi.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Prenyltransferases produce intermediates in isoprenoid pathways, which could be described as 'metabolic intermediate biosynthesis' (option A) in a broad sense. The classification as 'secondary metabolite biosynthesis' (option B) reflects the specific downstream product (sporulositol A) rather than a property uniquely readable from the enzyme's sequence. Without the specific substrate/product annotation, both A and B have some plausibility, though B is the more precise UniProt-assigned pathway.


### Important caveats

- The organism (Viridothelium virens, a lichen-forming fungus) is not stated in the question; the model must infer eukaryotic/fungal origin from sequence features alone.
- The pathway annotation is based on a single 2024 experimental study (PubMed:39310987); the EC number remains 2.5.1.- (unassigned subclass), indicating incomplete mechanistic characterization.
- The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must work from sequence and general knowledge only.
- Option C (peptidoglycan degradation) is trivially wrong for a fungal protein, and option D (histidine biosynthesis) is inconsistent with the membrane-protein architecture, but these easy eliminations do not resolve the A-vs-B ambiguity.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "One could argue that fungal membrane-bound prenyltransferases with multiple TM domains are predominantly involved in secondary metabolite (terpenoid) biosynthesis rather than primary metabolic intermediate production. Options C (peptidoglycan degradation) and D (histidine biosynthesis) are readily excluded for a eukaryotic membrane protein. However, the critical A-vs-B distinction ('metabolic intermediate biosynthesis' vs. 'secondary metabolite biosynthesis') hinges on whether the prenylated product is a primary or secondary metabolite, which is not determinable from sequence features alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific substrate and product identity of this enzyme (cyclo-farnesyl diphosphate-dependent prenylation producing sporulositol A, a secondary metabolite) is required to definitively assign the pathway as 'secondary metabolite biosynthesis' rather than the more generic 'metabolic intermediate biosynthesis.' Prenyltransferases can function in both primary (e.g., ubiquinone biosynthesis) and secondary metabolism, and the sequence alone does not encode which class of product is formed.",
    "reason": "While a knowledgeable model might narrow choices by recognizing prenyltransferase motifs and fungal membrane-protein architecture, the decisive distinction between option A (metabolic intermediate biosynthesis) and option B (secondary metabolite biosynthesis) depends on knowing this particular enzyme's role in sporulositol A biosynthesis—a specific experimental finding from PubMed:39310987. No general sequence heuristic reliably separates primary from secondary metabolite prenylation in fungi."
  },
  "case_id": "pathway_0177",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A6A6H402 (Prenyltransferase vviA / Sporulositol A biosynthesis cluster protein A) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987, a 2024 Org. Lett. paper on cyclo-farnesyl diphosphate-dependent prenylation in fungi). The sequence matches exactly (293 AA, SHA-256 confirmed). The protein catalyzes prenylation in sporulositol A biosynthesis, a fungal secondary metabolite. The expected answer B is directly supported."
  },
  "important_caveats": [
    "The organism (Viridothelium virens, a lichen-forming fungus) is not stated in the question; the model must infer eukaryotic/fungal origin from sequence features alone.",
    "The pathway annotation is based on a single 2024 experimental study (PubMed:39310987); the EC number remains 2.5.1.- (unassigned subclass), indicating incomplete mechanistic characterization.",
    "The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must work from sequence and general knowledge only.",
    "Option C (peptidoglycan degradation) is trivially wrong for a fungal protein, and option D (histidine biosynthesis) is inconsistent with the membrane-protein architecture, but these easy eliminations do not resolve the A-vs-B ambiguity."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Prenyltransferases produce intermediates in isoprenoid pathways, which could be described as 'metabolic intermediate biosynthesis' (option A) in a broad sense. The classification as 'secondary metabolite biosynthesis' (option B) reflects the specific downstream product (sporulositol A) rather than a property uniquely readable from the enzyme's sequence. Without the specific substrate/product annotation, both A and B have some plausibility, though B is the more precise UniProt-assigned pathway."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0177",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A6A6H402 (Prenyltransferase vviA / Sporulositol A biosynthesis cluster protein A) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987, a 2024 Org. Lett. paper on cyclo-farnesyl diphosphate-dependent prenylation in fungi). The sequence matches exactly (293 AA, SHA-256 confirmed). The protein catalyzes prenylation in sporulositol A biosynthesis, a fungal secondary metabolite. The expected answer B is directly supported.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "One could argue that fungal membrane-bound prenyltransferases with multiple TM domains are predominantly involved in secondary metabolite (terpenoid) biosynthesis rather than primary metabolic intermediate production. Options C (peptidoglycan degradation) and D (histidine biosynthesis) are readily excluded for a eukaryotic membrane protein. However, the critical A-vs-B distinction ('metabolic intermediate biosynthesis' vs. 'secondary metabolite biosynthesis') hinges on whether the prenylated product is a primary or secondary metabolite, which is not determinable from sequence features alone.",
    "missing_item_specific_fact": "The specific substrate and product identity of this enzyme (cyclo-farnesyl diphosphate-dependent prenylation producing sporulositol A, a secondary metabolite) is required to definitively assign the pathway as 'secondary metabolite biosynthesis' rather than the more generic 'metabolic intermediate biosynthesis.' Prenyltransferases can function in both primary (e.g., ubiquinone biosynthesis) and secondary metabolism, and the sequence alone does not encode which class of product is formed.",
    "reason": "While a knowledgeable model might narrow choices by recognizing prenyltransferase motifs and fungal membrane-protein architecture, the decisive distinction between option A (metabolic intermediate biosynthesis) and option B (secondary metabolite biosynthesis) depends on knowing this particular enzyme's role in sporulositol A biosynthesis—a specific experimental finding from PubMed:39310987. No general sequence heuristic reliably separates primary from secondary metabolite prenylation in fungi."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Prenyltransferases produce intermediates in isoprenoid pathways, which could be described as 'metabolic intermediate biosynthesis' (option A) in a broad sense. The classification as 'secondary metabolite biosynthesis' (option B) reflects the specific downstream product (sporulositol A) rather than a property uniquely readable from the enzyme's sequence. Without the specific substrate/product annotation, both A and B have some plausibility, though B is the more precise UniProt-assigned pathway."
  },
  "important_caveats": [
    "The organism (Viridothelium virens, a lichen-forming fungus) is not stated in the question; the model must infer eukaryotic/fungal origin from sequence features alone.",
    "The pathway annotation is based on a single 2024 experimental study (PubMed:39310987); the EC number remains 2.5.1.- (unassigned subclass), indicating incomplete mechanistic characterization.",
    "The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must work from sequence and general knowledge only.",
    "Option C (peptidoglycan degradation) is trivially wrong for a fungal protein, and option D (histidine biosynthesis) is inconsistent with the membrane-protein architecture, but these easy eliminations do not resolve the A-vs-B ambiguity."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record assigns this protein to secondary metabolite biosynthesis, with a terpenoid-biosynthesis annotation linked to a publication and experimental evidence code. This supports choice B, though the cited study was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The strongly hydrophobic sequence suggests a multipass membrane protein, plausibly a membrane-associated prenyltransferase. That makes secondary-metabolite biosynthesis plausible, but prenyltransferases can serve different pathways, including primary metabolism; the sequence alone does not establish the relevant substrate or pathway.


**Missing item-specific fact**

> Whether this protein's prenyltransferase activity acts in a specialized secondary-metabolite pathway rather than primary metabolic-intermediate biosynthesis.


**Reason**

> The sequence provides a plausible enzyme-class clue but not a meaningful basis for reliably distinguishing the two broad pathway choices A and B. Resolving that distinction requires the protein's specific biological role or pathway context, which is absent from the original input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> The membrane-protein character can suggest a prenyltransferase, but does not specify whether its pathway is primary metabolism or secondary-metabolite biosynthesis.


### Important caveats

- The pathway annotation is reviewer-only evidence and was not part of the original input.
- The source annotation supports the key but does not by itself establish that the pathway can be identified from sequence alone.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The strongly hydrophobic sequence suggests a multipass membrane protein, plausibly a membrane-associated prenyltransferase. That makes secondary-metabolite biosynthesis plausible, but prenyltransferases can serve different pathways, including primary metabolism; the sequence alone does not establish the relevant substrate or pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "Whether this protein's prenyltransferase activity acts in a specialized secondary-metabolite pathway rather than primary metabolic-intermediate biosynthesis.",
    "reason": "The sequence provides a plausible enzyme-class clue but not a meaningful basis for reliably distinguishing the two broad pathway choices A and B. Resolving that distinction requires the protein's specific biological role or pathway context, which is absent from the original input."
  },
  "case_id": "pathway_0177",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record assigns this protein to secondary metabolite biosynthesis, with a terpenoid-biosynthesis annotation linked to a publication and experimental evidence code. This supports choice B, though the cited study was not independently reviewed here."
  },
  "important_caveats": [
    "The pathway annotation is reviewer-only evidence and was not part of the original input.",
    "The source annotation supports the key but does not by itself establish that the pathway can be identified from sequence alone."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "The membrane-protein character can suggest a prenyltransferase, but does not specify whether its pathway is primary metabolism or secondary-metabolite biosynthesis."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0177",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record assigns this protein to secondary metabolite biosynthesis, with a terpenoid-biosynthesis annotation linked to a publication and experimental evidence code. This supports choice B, though the cited study was not independently reviewed here.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The strongly hydrophobic sequence suggests a multipass membrane protein, plausibly a membrane-associated prenyltransferase. That makes secondary-metabolite biosynthesis plausible, but prenyltransferases can serve different pathways, including primary metabolism; the sequence alone does not establish the relevant substrate or pathway.",
    "missing_item_specific_fact": "Whether this protein's prenyltransferase activity acts in a specialized secondary-metabolite pathway rather than primary metabolic-intermediate biosynthesis.",
    "reason": "The sequence provides a plausible enzyme-class clue but not a meaningful basis for reliably distinguishing the two broad pathway choices A and B. Resolving that distinction requires the protein's specific biological role or pathway context, which is absent from the original input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "The membrane-protein character can suggest a prenyltransferase, but does not specify whether its pathway is primary metabolism or secondary-metabolite biosynthesis."
  },
  "important_caveats": [
    "The pathway annotation is reviewer-only evidence and was not part of the original input.",
    "The source annotation supports the key but does not by itself establish that the pathway can be identified from sequence alone."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation (evidence C5, H3) explicitly states PATHWAY: 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed:39310987. The protein is annotated as Prenyltransferase vviA (EC 2.5.1.-), a membrane-bound enzyme catalyzing prenylation in Sporulositol A biosynthesis. This experimental annotation directly supports choice B.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 293-aa sequence displays approximately 5-6 long hydrophobic stretches (e.g., residues ~10-30, ~50-80, ~95-120, ~140-170, ~195-220, ~240-270) consistent with a multi-pass membrane protein. Membrane-bound prenyltransferases (UbiA-family and related fungal prenyltransferases) are a well-characterized family whose defining topology is multiple transmembrane helices. In fungi, these membrane-bound prenyltransferases catalyze prenylation of terpenoid scaffolds and are universally classified under secondary metabolite biosynthesis (terpenoid biosynthesis), not primary metabolic intermediate biosynthesis. Against distractor C (peptidoglycan degradation): peptidoglycan-degrading enzymes (lysozymes, amidases, transglycosylases) are soluble or periplasmic with entirely different folds and lack multi-TM architecture. Against distractor D (histidine biosynthesis step 4/9): histidine biosynthesis enzymes (e.g., HisA, HisF) are soluble cytoplasmic TIM-barrel proteins with no transmembrane segments. Against distractor A (metabolic intermediate biosynthesis): this term in pathway databases (MetaCyc, UniProt) refers to primary metabolism intermediates (amino acids, nucleotides, cofactors); prenylation of terpenoid scaffolds is specifically categorized under secondary metabolism. Thus the multi-TM membrane topology plus fungal context points to secondary metabolite biosynthesis via the well-known membrane-bound prenyltransferase family.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The multi-transmembrane topology is directly observable from the hydrophobic stretches in the supplied sequence. Knowledge that membrane-bound prenyltransferases in fungi belong to secondary metabolite (terpenoid) biosynthesis is a well-established family-level pattern transferable from other fungal prenyltransferases. The distractors C and D are eliminated by topology mismatch (soluble enzymes), and A is eliminated by the standard pathway classification of prenylation reactions as secondary metabolism rather than primary metabolic intermediate biosynthesis.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> While A (metabolic intermediate biosynthesis) and B (secondary metabolite biosynthesis) could superficially seem similar, the standard pathway classification places prenyltransferase-mediated terpenoid modifications firmly under secondary metabolite biosynthesis. The multi-TM membrane architecture eliminates C and D unambiguously. No genuine ambiguity remains among the offered choices.


### Important caveats

- The UniProt annotation carries experimental evidence (ECO:0000269) from a 2024 Org. Lett. paper, confirming the pathway assignment is not merely computational.
- The term 'metabolic intermediate biosynthesis' (option A) is broad and could in principle encompass some prenylation steps, but in standard pathway ontology it refers to primary metabolism, making B the clearly correct classification for a terpenoid prenyltransferase.
- The protein is from a lichen-forming fungus (Viridothelium virens); fungal secondary metabolite biosynthesis is well-established as a major category of membrane-bound enzyme function.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 293-aa sequence displays approximately 5-6 long hydrophobic stretches (e.g., residues ~10-30, ~50-80, ~95-120, ~140-170, ~195-220, ~240-270) consistent with a multi-pass membrane protein. Membrane-bound prenyltransferases (UbiA-family and related fungal prenyltransferases) are a well-characterized family whose defining topology is multiple transmembrane helices. In fungi, these membrane-bound prenyltransferases catalyze prenylation of terpenoid scaffolds and are universally classified under secondary metabolite biosynthesis (terpenoid biosynthesis), not primary metabolic intermediate biosynthesis. Against distractor C (peptidoglycan degradation): peptidoglycan-degrading enzymes (lysozymes, amidases, transglycosylases) are soluble or periplasmic with entirely different folds and lack multi-TM architecture. Against distractor D (histidine biosynthesis step 4/9): histidine biosynthesis enzymes (e.g., HisA, HisF) are soluble cytoplasmic TIM-barrel proteins with no transmembrane segments. Against distractor A (metabolic intermediate biosynthesis): this term in pathway databases (MetaCyc, UniProt) refers to primary metabolism intermediates (amino acids, nucleotides, cofactors); prenylation of terpenoid scaffolds is specifically categorized under secondary metabolism. Thus the multi-TM membrane topology plus fungal context points to secondary metabolite biosynthesis via the well-known membrane-bound prenyltransferase family.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The multi-transmembrane topology is directly observable from the hydrophobic stretches in the supplied sequence. Knowledge that membrane-bound prenyltransferases in fungi belong to secondary metabolite (terpenoid) biosynthesis is a well-established family-level pattern transferable from other fungal prenyltransferases. The distractors C and D are eliminated by topology mismatch (soluble enzymes), and A is eliminated by the standard pathway classification of prenylation reactions as secondary metabolism rather than primary metabolic intermediate biosynthesis."
  },
  "case_id": "pathway_0177",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation (evidence C5, H3) explicitly states PATHWAY: 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed:39310987. The protein is annotated as Prenyltransferase vviA (EC 2.5.1.-), a membrane-bound enzyme catalyzing prenylation in Sporulositol A biosynthesis. This experimental annotation directly supports choice B."
  },
  "important_caveats": [
    "The UniProt annotation carries experimental evidence (ECO:0000269) from a 2024 Org. Lett. paper, confirming the pathway assignment is not merely computational.",
    "The term 'metabolic intermediate biosynthesis' (option A) is broad and could in principle encompass some prenylation steps, but in standard pathway ontology it refers to primary metabolism, making B the clearly correct classification for a terpenoid prenyltransferase.",
    "The protein is from a lichen-forming fungus (Viridothelium virens); fungal secondary metabolite biosynthesis is well-established as a major category of membrane-bound enzyme function."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While A (metabolic intermediate biosynthesis) and B (secondary metabolite biosynthesis) could superficially seem similar, the standard pathway classification places prenyltransferase-mediated terpenoid modifications firmly under secondary metabolite biosynthesis. The multi-TM membrane architecture eliminates C and D unambiguously. No genuine ambiguity remains among the offered choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0177",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation (evidence C5, H3) explicitly states PATHWAY: 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed:39310987. The protein is annotated as Prenyltransferase vviA (EC 2.5.1.-), a membrane-bound enzyme catalyzing prenylation in Sporulositol A biosynthesis. This experimental annotation directly supports choice B.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 293-aa sequence displays approximately 5-6 long hydrophobic stretches (e.g., residues ~10-30, ~50-80, ~95-120, ~140-170, ~195-220, ~240-270) consistent with a multi-pass membrane protein. Membrane-bound prenyltransferases (UbiA-family and related fungal prenyltransferases) are a well-characterized family whose defining topology is multiple transmembrane helices. In fungi, these membrane-bound prenyltransferases catalyze prenylation of terpenoid scaffolds and are universally classified under secondary metabolite biosynthesis (terpenoid biosynthesis), not primary metabolic intermediate biosynthesis. Against distractor C (peptidoglycan degradation): peptidoglycan-degrading enzymes (lysozymes, amidases, transglycosylases) are soluble or periplasmic with entirely different folds and lack multi-TM architecture. Against distractor D (histidine biosynthesis step 4/9): histidine biosynthesis enzymes (e.g., HisA, HisF) are soluble cytoplasmic TIM-barrel proteins with no transmembrane segments. Against distractor A (metabolic intermediate biosynthesis): this term in pathway databases (MetaCyc, UniProt) refers to primary metabolism intermediates (amino acids, nucleotides, cofactors); prenylation of terpenoid scaffolds is specifically categorized under secondary metabolism. Thus the multi-TM membrane topology plus fungal context points to secondary metabolite biosynthesis via the well-known membrane-bound prenyltransferase family.",
    "missing_item_specific_fact": "",
    "reason": "The multi-transmembrane topology is directly observable from the hydrophobic stretches in the supplied sequence. Knowledge that membrane-bound prenyltransferases in fungi belong to secondary metabolite (terpenoid) biosynthesis is a well-established family-level pattern transferable from other fungal prenyltransferases. The distractors C and D are eliminated by topology mismatch (soluble enzymes), and A is eliminated by the standard pathway classification of prenylation reactions as secondary metabolism rather than primary metabolic intermediate biosynthesis."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While A (metabolic intermediate biosynthesis) and B (secondary metabolite biosynthesis) could superficially seem similar, the standard pathway classification places prenyltransferase-mediated terpenoid modifications firmly under secondary metabolite biosynthesis. The multi-TM membrane architecture eliminates C and D unambiguously. No genuine ambiguity remains among the offered choices."
  },
  "important_caveats": [
    "The UniProt annotation carries experimental evidence (ECO:0000269) from a 2024 Org. Lett. paper, confirming the pathway assignment is not merely computational.",
    "The term 'metabolic intermediate biosynthesis' (option A) is broad and could in principle encompass some prenylation steps, but in standard pathway ontology it refers to primary metabolism, making B the clearly correct classification for a terpenoid prenyltransferase.",
    "The protein is from a lichen-forming fungus (Viridothelium virens); fungal secondary metabolite biosynthesis is well-established as a major category of membrane-bound enzyme function."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A6A6H402",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "897fc4df843bf85f1cdd0a1f4daa86fcaba8dd7ff09001216f7df7ed7a613ef7",
  "benchmark_sequence_length": 293,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 13,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2020-06-17",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "b8205d729e2e5bd4217fba29840a41164bb96c507173b89acd7a02b8a587f862",
  "current_source_sequence_sha256": "897fc4df843bf85f1cdd0a1f4daa86fcaba8dd7ff09001216f7df7ed7a613ef7",
  "current_source_sequence_length": 293,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 12,
  "selected_historical_version": {
    "accession": "A0A6A6H402",
    "database": "Swiss-Prot",
    "entryVersion": 12,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "VVIA_VIRVR",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "f3fb0188f37dd39fa5b2add2435b66089c72d61d50cfdb8351cca69e37efe727",
  "selected_historical_source_sequence_sha256": "897fc4df843bf85f1cdd0a1f4daa86fcaba8dd7ff09001216f7df7ed7a613ef7",
  "selected_historical_source_sequence_length": 293,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 12,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H402.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H402.json",
  "source_sha256": "b8205d729e2e5bd4217fba29840a41164bb96c507173b89acd7a02b8a587f862",
  "retrieved_utc": "2026-11-02T04:25:32.724960+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A6A6H402\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H402.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H402.json",
  "source_sha256": "b8205d729e2e5bd4217fba29840a41164bb96c507173b89acd7a02b8a587f862",
  "retrieved_utc": "2026-11-02T04:25:32.724960+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":13,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2020-06-17\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H402.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H402.json",
  "source_sha256": "b8205d729e2e5bd4217fba29840a41164bb96c507173b89acd7a02b8a587f862",
  "retrieved_utc": "2026-11-02T04:25:32.724960+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Speckled blister lichen\",\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Dothideomycetes\",\"Dothideomycetes incertae sedis\",\"Trypetheliales\",\"Trypetheliaceae\",\"Viridothelium\"],\"scientificName\":\"Viridothelium virens\",\"synonyms\":[\"Trypethelium virens\"],\"taxonId\":1048519}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H402.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H402.json",
  "source_sha256": "b8205d729e2e5bd4217fba29840a41164bb96c507173b89acd7a02b8a587f862",
  "retrieved_utc": "2026-11-02T04:25:32.724960+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39310987\",\"source\":\"PubMed\"}],\"value\":\"Sporulositol A biosynthesis cluster protein A\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39310987\",\"source\":\"PubMed\"}],\"value\":\"2.5.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39310987\",\"source\":\"PubMed\"}],\"value\":\"Prenyltransferase vviA\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H402.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H402.json",
  "source_sha256": "b8205d729e2e5bd4217fba29840a41164bb96c507173b89acd7a02b8a587f862",
  "retrieved_utc": "2026-11-02T04:25:32.724960+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39310987\",\"source\":\"PubMed\"}],\"value\":\"Secondary metabolite biosynthesis; terpenoid biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H402.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H402.json",
  "source_sha256": "b8205d729e2e5bd4217fba29840a41164bb96c507173b89acd7a02b8a587f862",
  "retrieved_utc": "2026-11-02T04:25:32.724960+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Tang Y.J.\",\"Zou Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39310987\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.orglett.4c03154\"}],\"citationType\":\"journal article\",\"firstPage\":\"8366\",\"id\":\"39310987\",\"journal\":\"Org. Lett.\",\"lastPage\":\"8370\",\"publicationDate\":\"2024\",\"title\":\"Cyclo-farnesyl Diphosphate-Dependent Prenylation in Fungi.\",\"volume\":\"26\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"COFACTOR\",\"PATHWAY\",\"MUTAGENESIS OF LEU-17; ASN-21; MET-24; LYS-63; HIS-115; TYR-137; ILE-151; ASP-189; TRP-192 AND THR-277\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A6A6H402?format=txt&versions=12)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A6A6H402?format=txt&versions=12",
  "source_sha256": "f3fb0188f37dd39fa5b2add2435b66089c72d61d50cfdb8351cca69e37efe727",
  "retrieved_utc": "2026-11-02T04:25:34.642719+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   VVIA_VIRVR              Reviewed;         293 AA.\nAC   A0A6A6H402;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   17-JUN-2020, sequence version 1.\nDT   28-JAN-2026, entry version 12.\nDE   RecName: Full=Prenyltransferase vviA {ECO:0000303|PubMed:39310987};\nDE            EC=2.5.1.- {ECO:0000269|PubMed:39310987};\nDE   AltName: Full=Sporulositol A biosynthesis cluster protein A {ECO:0000303|PubMed:39310987};\nGN   Name=vviA {ECO:0000303|PubMed:39310987}; ORFNames=EV356DRAFT_253807;\nOS   Viridothelium virens (Speckled blister lichen) (Trypethelium virens).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;\nOC   Dothideomycetes incertae sedis; Trypetheliales; Trypetheliaceae;\nOC   Viridothelium.\nOX   NCBI_TaxID=1048519;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 12,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A6A6H402?format=txt&versions=12)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A6A6H402?format=txt&versions=12",
  "source_sha256": "f3fb0188f37dd39fa5b2add2435b66089c72d61d50cfdb8351cca69e37efe727",
  "retrieved_utc": "2026-11-02T04:25:34.642719+00:00",
  "source_locator": "lines 29-36",
  "excerpt": "RN   [2]\nRP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, PATHWAY, AND MUTAGENESIS OF LEU-17;\nRP   ASN-21; MET-24; LYS-63; HIS-115; TYR-137; ILE-151; ASP-189; TRP-192 AND\nRP   THR-277.\nRX   PubMed=39310987; DOI=10.1021/acs.orglett.4c03154;\nRA   Tang Y.J., Zou Y.;\nRT   \"Cyclo-farnesyl Diphosphate-Dependent Prenylation in Fungi.\";\nRL   Org. Lett. 26:8366-8370(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 12,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A6A6H402?format=txt&versions=12)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A6A6H402?format=txt&versions=12",
  "source_sha256": "f3fb0188f37dd39fa5b2add2435b66089c72d61d50cfdb8351cca69e37efe727",
  "retrieved_utc": "2026-11-02T04:25:34.642719+00:00",
  "source_locator": "lines 58-59",
  "excerpt": "CC   -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.\nCC       {ECO:0000269|PubMed:39310987}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 12,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 177. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
